Philip D Worboys's most recent trade in Theravance Biopharma Inc was a trade of 4,310 Ordinary Shares done at an average price of $8.4 . Disclosure was reported to the exchange on Nov. 19, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Theravance Biopharma Inc | Philip D. Worboys | SVP, RESEARCH & TRANSL SCIENCE | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.36 per share. | 19 Nov 2021 | 4,310 | 330,752 (0%) | 0% | 8.4 | 36,032 | Ordinary Shares |
| Theravance Biopharma Inc | Philip D. Worboys | SVP, Research & Transl Science | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.05 per share. | 20 Aug 2021 | 4,307 | 335,062 (0%) | 0% | 14.0 | 60,513 | Ordinary Shares |
| Theravance Biopharma Inc | Philip D. Worboys | SVP, Research & Transl Science | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.80 per share. | 20 May 2021 | 4,310 | 339,369 (0%) | 0% | 17.8 | 76,718 | Ordinary Shares |